L-Citrulline - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The L-Citrulline market size was estimated at USD 1.77 billion in 2025 and is estimated to grow from USD 1.84 billion in 2026 to USD 2.36 billion by 2031, at a CAGR of 5.14% during the forecast period (2026-2031). This report is segmented by Form (Powder, Capsule, and More), Classification (Food Grade and Medical Grade), Application (Food and Beverages, Pharmaceuticals, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global L-Citrulline Market Trends and Insights

Sports Nutrition and Non-Stimulant Performance Formulations

The L-citrulline market benefits from growing consumer interest in non-stimulant pre-workout products that provide performance support without relying on caffeine. Consumers concerned about stimulant-related effects choose products positioned around muscle blood flow, endurance, and recovery rather than short-lived stimulant effects. L-citrulline supports nitric oxide production through the arginine, endothelial nitric oxide synthase, and nitric oxide pathway. It also supports ammonia and lactate clearance through the hepatic urea cycle, distinguishing its role from ingredients that only mask fatigue. A 2025 narrative review described a combination of 200 mg Setria Glutathione and 2 g L-citrulline that supported nitric oxide production and lean-mass outcomes. The 6 g to 10 g per-serving range used in many U.S. pre-workout products increases raw-material demand per unit and supports fermented products with disclosed sourcing and clinically relevant serving sizes. It also encourages brands to communicate ingredient origin, fermentation methods, dose selection, and intended use more clearly to consumers comparing products online.

Functional Foods, Beverages, and Hydration Products

Functional foods, beverages, and hydration products represent a demand channel for the L-citrulline market beyond periodic supplement use. Daily hydration and snack occasions generate more regular purchase behavior than standalone performance products, which are often used in cycles. L-citrulline powder has a mildly sweet, near-neutral sensory profile that fits well in lightly flavored drinks and energy shots, requiring less masking than many performance amino acids. Japan's dietary supplement market reached JPY 1.0876 trillion (USD 7.4 billion) in 2025, with citrulline among the active functional ingredients. A 2025 study in dairy goats found that dietary L-citrulline increased milk protein concentration, indicating a potential application beyond human nutrition. This broadens the range of customers evaluating the ingredient for feed and agricultural formulations, while daily food formats provide a stable route to consumer adoption. Sports drinks, electrolyte blends, energy shots, and powdered hydration products allow companies to position L-citrulline within familiar product formats rather than as a specialized amino acid purchase.

High-Purity Fermentation and Purification Costs

Pharmaceutical-grade L-citrulline requires purity above 99.5% under Good Manufacturing Practice requirements. Crystallization, ion-exchange chromatography, filtration, and endotoxin removal raise manufacturing costs by 20% to 40% compared with standard food-grade output. Fermentation improvements reduce upstream costs but do not eliminate the need for investment in downstream purification equipment, validation, and batch release. This creates a barrier for smaller producers seeking to enter the pharmaceutical supply and compete for regulated customer accounts. Clinical applications also require 12 to 36 months of stability data in accordance with International Council for Harmonization quality expectations. The L-citrulline market has a structural divide between producers that can document pharmaceutical quality and those limited to lower-margin food-grade supply. This difference affects capital planning, customer qualification, production scheduling, and participation in trials or regulated nutrition programs.

Other drivers and restraints analyzed in the detailed report include:

• Cardiovascular and Healthy-Aging Demand
• Fermentation-Based Clean-Label Supply Expansion
• Taste, Acidity, and Liquid-Format Stability Constraints

Segment Analysis

Powder held 53.45% of the L-citrulline market share in 2025 and is forecast to expand at a 6.06% CAGR through 2031. It is the preferred delivery format for sports nutrition brands, functional food producers, and pharmaceutical formulators because it enables high inclusion levels without the storage constraints associated with liquid products. The format supports servings from 1 g to more than 10 g, allowing manufacturers to offer lower-dose wellness products and higher-dose performance products from a comparable base ingredient. Powder is also easier to incorporate into flavored beverage blends than citrulline malate tablets or ready-to-drink liquids with pronounced sour notes. CJ BIO's AMINATURE uses non-GMO microbial fermentation and is suitable for vegan product applications.

Capsules address consumers who prefer convenience, controlled dosing, and a swallowable product, particularly in cardiovascular wellness and over-the-counter formats. Liquid products are attracting investment in the United States and Asia-Pacific despite acidity, sensory, and shelf-life limitations that affect ambient distribution. A 2025 study reported a 73.4% encapsulation efficiency for chitosan-coated nanoliposomes containing L-citrulline, with controlled release under simulated gastrointestinal conditions. This approach provides a technical route for future liquid delivery systems but does not remove the need for careful high-dose formulation and stable packaging. The L-citrulline market favors powder as direct-to-consumer subscriptions support bulk formats, repeat purchases, efficient distribution, and clear dosing instructions. The powder format also allows brands to adapt serving sizes for pre-workout, hydration, and cardiovascular wellness products without changing the core delivery platform.

Complete Report Scope:

• By Form
  • Powder
  • Capsule
  • Liquid
• By Classification
  • Food Grade
  • Medical Grade
• By Application
  • Food and Beverages
  • Pharmaceuticals
  • Cosmetics and Personal Care
  • Agriculture and Animal Feed
  • Other Applications
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America accounted for 40.24% of the L-citrulline market share in 2025. This position reflects the United States' established dietary supplement industry, high consumer spending on fitness nutrition, and mature direct-to-consumer e-commerce channels. The Dietary Supplement Health and Education Act governs the sale and labeling of L-citrulline products, while the region's clinical research base supports both food-grade sports products and pharmaceutical-grade formulations. Large retail networks, specialist stores, and digital subscription models support brands in offering multiple dosage formats. These factors make North America a key destination for suppliers that can demonstrate consistent quality and responsive distribution. Established consumer awareness of workout supplements and multiple retail channels allow suppliers to serve performance, general wellness, and clinical-oriented buyers within the same regional market.

Asia-Pacific is forecast to be the fastest-growing region at a 5.89% CAGR through 2031. Rising urban incomes, organized fitness participation, and aging populations in Japan, South Korea, and China are driving demand in the L-citrulline market. Japan's dietary supplement industry reached JPY 1.0876 trillion (USD 7.4 billion) in 2025, with citrulline among the active functional ingredients. China combines a fermentation-based amino acid production base with a growing domestic supplement market, while South Korea supports branded ingredients and high-purity supply. India remains less developed, but online access to global supplement brands is supporting adoption among urban fitness consumers. These conditions allow the L-citrulline market to develop initially through imported brands, followed by local manufacturing and private-label activity as consumer familiarity grows.

Europe is the second-largest regional market, with Germany, the United Kingdom, and France supporting demand under health-claim regulations for food products. European buyers prioritize traceability, food safety certification, and clear product documentation, which encourages producers to adopt ISO 22000 or Food Safety System Certification (FSSC) 22000 practices. South America remains at an earlier stage of development, with Brazil serving as the regional anchor through its urban fitness culture. Demand in the Middle East and Africa is concentrated in Gulf Cooperation Council markets with premium supplement retail networks, presenting further growth opportunities for the L-citrulline market as distribution expands.

List of Companies Covered in this Report:

• Acerblend Ingredients Co., Ltd.
• CJ CHEILJEDANG CORP
• Daesang Corporation
• Glanbia plc
• Hebei Huaheng Biologcal Technology Co,Ltd.
• Hubei Yuanda Biotechnology Co., Ltd.
• KYOWA HAKKO BIO CO., LTD.
• Meihua Holdings Group Co., Ltd.
• MH2 BIOCHEMICAL
• Now Health International
• NutraBio
• Shanghai Joinray Biotechnology Co., Ltd.
• Shijiazhuang Haitian Amino Acid Co., Ltd.
• Tomo Chemical Co., Ltd.
• Wuxi Jinghai Amino Acid Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support